Cerity Partners LLC Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cerity Partners LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 139,175 shares of the medical equipment provider’s stock after acquiring an additional 13,188 shares during the quarter. Cerity Partners LLC’s holdings in Intuitive Surgical were worth $68,372,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Advisors Asset Management Inc. increased its stake in shares of Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares during the last quarter. Lavaca Capital LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $216,000. Silvercrest Asset Management Group LLC increased its position in Intuitive Surgical by 25.0% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 60,339 shares of the medical equipment provider’s stock worth $24,081,000 after purchasing an additional 12,056 shares in the last quarter. Waverly Advisors LLC increased its position in Intuitive Surgical by 27.1% during the 1st quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock worth $1,018,000 after purchasing an additional 544 shares in the last quarter. Finally, Benchmark Investment Advisors LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $206,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 396 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,680,761.28. This trade represents a 6.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,935 shares of company stock worth $26,305,169 over the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Down 0.5 %

Intuitive Surgical stock opened at $547.87 on Friday. The stock has a market cap of $195.14 billion, a P/E ratio of 88.08, a price-to-earnings-growth ratio of 5.41 and a beta of 1.39. The stock has a 50 day moving average of $504.73 and a 200-day moving average of $463.54. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ISRG. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.